The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(4-(2-(4-methyl-1H-benzo[d]imidazol-2-yl)-5,6-dihydro-4H-benzo[b]thieno[2,3-d]azepine-6-carbonyl)phenyl)-2-(7-oxa-2-azaspiro[3.5]nonan-2-yl)nicotinamide ID: ALA4090210
PubChem CID: 121425603
Max Phase: Preclinical
Molecular Formula: C40H36N6O3S
Molecular Weight: 680.83
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: Cc1cccc2[nH]c(-c3cc4c(s3)-c3ccccc3N(C(=O)c3ccc(NC(=O)c5cccnc5N5CC6(CCOCC6)C5)cc3)CC4)nc12
Standard InChI: InChI=1S/C40H36N6O3S/c1-25-6-4-9-31-34(25)44-36(43-31)33-22-27-15-19-46(32-10-3-2-7-29(32)35(27)50-33)39(48)26-11-13-28(14-12-26)42-38(47)30-8-5-18-41-37(30)45-23-40(24-45)16-20-49-21-17-40/h2-14,18,22H,15-17,19-21,23-24H2,1H3,(H,42,47)(H,43,44)
Standard InChI Key: GEMXANAXDBFEFD-UHFFFAOYSA-N
Molfile:
RDKit 2D
50 58 0 0 0 0 0 0 0 0999 V2000
13.6776 -7.4827 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3834 -7.0699 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3789 -6.2569 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6702 -5.8504 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.9644 -6.2631 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9674 -7.0823 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.9828 -9.8640 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9817 -10.6836 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6897 -11.0925 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3994 -10.6831 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.3966 -9.8604 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6880 -9.4552 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6855 -8.6380 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.2584 -8.0612 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.1027 -8.0646 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.1027 -9.4492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.8120 -9.8551 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
15.0997 -8.6320 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
16.5181 -9.4438 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2258 -9.8532 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9315 -9.4426 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9289 -8.6245 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.2146 -8.2188 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5119 -8.6317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6345 -8.2123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.3443 -8.6173 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.6303 -7.3952 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
19.3697 -7.0342 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.5460 -6.2348 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9019 -7.0468 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7117 -6.2469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9254 -6.0132 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3285 -6.5783 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.5233 -7.3803 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.3093 -7.6104 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.2089 -5.6050 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0294 -5.6003 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2786 -4.8185 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.6120 -4.3399 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.9510 -4.8261 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
18.6043 -3.5220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.2626 -3.0378 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.9405 -3.0454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
18.1884 -2.2668 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.0035 -2.2644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
19.4072 -1.5585 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.9969 -0.8545 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.1788 -0.8608 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.7788 -1.5673 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9616 -1.5732 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
1 6 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 11 1 0
11 12 2 0
12 7 1 0
12 13 1 0
13 14 1 0
14 1 1 0
1 15 1 0
15 13 1 0
11 16 1 0
16 17 1 0
16 18 2 0
17 19 1 0
19 20 2 0
20 21 1 0
21 22 2 0
22 23 1 0
23 24 2 0
24 19 1 0
22 25 1 0
25 26 2 0
25 27 1 0
27 30 1 0
27 28 1 0
31 36 1 0
28 29 1 0
29 37 1 0
30 31 2 0
31 32 1 0
32 33 2 0
33 34 1 0
34 35 2 0
35 30 1 0
36 37 2 0
37 38 1 0
38 39 2 0
39 40 1 0
40 36 1 0
41 42 1 0
42 45 1 0
44 43 1 0
43 41 2 0
39 41 1 0
44 45 2 0
45 46 1 0
46 47 2 0
47 48 1 0
48 49 2 0
49 44 1 0
49 50 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 680.83Molecular Weight (Monoisotopic): 680.2570AlogP: 7.73#Rotatable Bonds: 5Polar Surface Area: 103.45Molecular Species: NEUTRALHBA: 7HBD: 2#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski): 2CX Acidic pKa: 11.20CX Basic pKa: 5.23CX LogP: 6.83CX LogD: 6.83Aromatic Rings: 6Heavy Atoms: 50QED Weighted: 0.19Np Likeness Score: -1.30
References 1. Fordyce EAF, Brookes DW, Lise-Ciana C, Coates MS, Hunt SF, Ito K, King-Underwood J, Onions ST, Parra GF, Rapeport G, Sherbukhin V, Stockwell JA, Strong P, Thomas JC, Murray J.. (2017) Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus., 27 (10): [PMID:28372911 ] [10.1016/j.bmcl.2017.03.053 ]